Skip to Main Content
CKG
Home
Home
Home
TKG
Paper Details
Breadcrumb
Paper Details
Paper Title
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer.
PubMed
Paper Journal Title
Cancers (Basel)
Paper Citation Count
14
Paper Publication Year
2021
Bio Mention
APOC1, BET, BET bromodomain, DNA, DNA repair proteins, Gemcitabine, H2AX, HMGCS2, I-BET762, JQ1, Ku80, LXR, MiaPaCa2, PC, Panc1, Pancreatic Cancer, RAD51, RXR, Su86 PC cell lines, antitumor, cholesterol, cleaved caspase 3, gemcitabine, pancreatic cancer, patient, patient-derived xenograft models, tumor, tumor cell
Mesh Descriptor
Go
Actions
Author Name
Affiliation
Dongquan Chen
University of Alabama at Birmingham
Dongquan Chen
University of Alabama at Birmingham
Eddy S Yang
University of Alabama at Birmingham
Eddy S Yang
University of Alabama at Birmingham
Eddy S Yang
O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham
Eddy S Yang
University of Alabama at Birmingham
Eddy S Yang
University of Alabama at Birmingham
Eddy S Yang
O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham
1 - 8
Column Actions
Search
Datasets